Immediate pharmacological blockade of the MR also ameliorates cardiac healing post-MI by reducing cardiac inflammation [28] and genetic ablation of the cardiomyocyte MR protects the heart in the transaortic constriction (TAC) model of pressure overload [29]. The gene discussed is NR3C2; the disease is inflammatory response.